Treatment of MRSA-infected osteomyelitis using bacterial capturing, magnetically targeted composites with microwave-assisted bacterial killing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32895387.
- Also identified by DOI 10.1038/s41467-020-18268-0 and PMC identifier 7477539.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Owing to the poor penetration depth of light, phototherapy, including photothermal and photodynamic therapies, remains severely ineffective in treating deep tissue infections such as methicillin-resistant Staphylococcus aureus (MRSA)-infected osteomyelitis. Here, we report a microwave-excited antibacterial nanocapturer system for treating deep tissue infections that consists of microwave-responsive Fe<sub>3</sub>O<sub>4</sub>/CNT and the chemotherapy agent gentamicin (Gent). This system, Fe<sub>3</sub>O<sub>4</sub>/CNT/Gent, is proven to efficiently target and eradicate MRSA-infected rabbit tibia osteomyelitis. Its robust antibacterial effectiveness is attributed to the precise bacteria-capturing ability and magnetic targeting of the nanocapturer, as well as the subsequent synergistic effects of precise microwaveocaloric therapy from Fe<sub>3</sub>O<sub>4</sub>/CNT and chemotherapy from the effective release of antibiotics in infection sites. The advanced target-nanocapturer of microwave-excited microwaveocaloric-chemotherapy with effective targeting developed in this study makes a major step forward in microwave therapy for deep tissue infections.
Medical subject headings
- Magnetite Nanoparticles
- Microwaves
- Osteomyelitis
- Staphylococcal Infections